Bionomics Limited

NASDAQ:BNOX

0.2531 (USD) • At close December 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q4
Revenue 150.663000.0990.0470.020.17300.0424.0640.12300.4670.0961.1961.133
Cost of Revenue 0000.4365.2682.4845.8972.9597.3253.4416.2445.0542.7811.58302.6810
Gross Profit 00.6630-0.436-5.169-2.438-5.552-2.787-7.235-3.399-2.18-4.931-2.539-1.1170.096-1.4851.133
Gross Profit Ratio 0100-52.25-52.25-277.617-16.130-80.036-0.536-40.0670-2.3941-1.2411
Reseach & Development Expenses 1.6161.7371.9011.1112.0352.4848.852.95910.763.4416.2445.0543.711.5831.3172.6810
General & Administrative Expenses 1.4072.6291.6670.3174.122.3793.0341.5232.7781.3051.9073.3691.711.61401.4230
Selling & Marketing Expenses 000-0.1850.0760.0360.0730.0370.0760.0360.0660.1210.4460.52200.3870
SG&A 1.4072.6291.6678,461.7922.5181.9794.661.5594.191.3411.9733.492.882.1362.251.813.003
Other Expenses 00000000000000000
Operating Expenses 3.0234.3663.5681.2434.5535.46817.182.56814.821.8763.8954.6137.141.4023.5682.6583.003
Operating Income 11.977-3.704-3.568-1.679-4.553-5.468-17.16-4.346-14.82-4.739-4.153-8.416-7.14-3.174-3.471-3.295-1.87
Operating Income Ratio 0.798-5.58800-46.018-117.187-858-25.1550-111.608-1.022-68.3890-6.804-36.067-2.754-1.65
Total Other Income Expenses Net -0.7961.7722.6312,313.767-0.182-0.557-0.453-0.9160.396-0.477-4.001-0.501-1.2633.093.661-2.6762.633
Income Before Tax 11.181-1.932-0.937-0.036-4.589-5.507-15.74-5.262-16.31-5.216-6.077-9.554-8.78-0.0840.19-4.6350.763
Income Before Tax Ratio 0.745-2.91500-46.386-118.039-787-30.4590-122.847-1.496-77.6340-0.181.972-3.8740.673
Income Tax Expense 0.0810.012-0.1320.046-0.11-0.035-0.10.034-0.10.0330.0670.069-0.090.074-0.0720.069-0.309
Net Income 11.262-1.943-0.805-0.081-4.554-5.473-15.64-5.228-16.21-5.183-6.011-9.484-8.68-0.01-0.465-4.5661.072
Net Income Ratio 0.751-2.93200-46.034-117.294-782-30.260-122.065-1.479-77.0730-0.021-4.831-3.8160.946
EPS 1,179-221.4-0.61-1.8-145.08-146.19-159.84-158.1-194.4-192.6-83.72-210.6-139.15-0.2820.88-18972.09
EPS Diluted 1,179-32.4-15.37-1.8-145.08-146.19-159.84-158.1-194.4-192.6-133.43-210.6-139.15-0.2820.88-18990.11
EBITDA 11.977-3.231-3.4020.401-4.292-5.302-10.959-4.191-11.005-4.591-10.355-9.724-6.4410.4240.847-3.7451.348
EBITDA Ratio 0.798-4.87600-43.386-113.631-547.959-24.2610-108.128-2.548-79.01600.9088.806-3.131.19